Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07129902 · ClinicalTrials.gov registry record · NA

Contingency Management to Improve Medication for Opioid Use Disorder Continuation After the Emergency Department

A NA study, sponsored by University of Vermont.

Recruiting
Registry status
NA
Development phase
30
Enrollment target

NCT07129902 is a NA study that is actively recruiting participants, run by University of Vermont. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07129902, a NA study, is actively recruiting participants, sponsored by University of Vermont.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

Project Summary The goal of this pilot clinical trial is to assess contingency management (CM) for increasing attendance at outpatient clinics after Medication for Opioid Use Disorder (MOUD) prescription and clinic referral occurred in the hospital Emergency Department (ED). * The researchers will compare usual care (UC)+CM to UC alone to see if 1) CM works to promote MOUD clinic attendance after discharge from the ED and 2) demonstrate feasibility of providing CM in the ED and outpatient MOUD clinic settings. * Researchers will randomize 30 adults who started MOUD in the ED into two conditions. These conditions consist of (A) UC alone: A referral to an outpatient buprenorphine or methadone provider with reminders from STAR program staff or (B) UC+CM: UC plus financial incentives dependent on MOUD clinic attendance to receive an MOUD prescription. The primary outcome of interest is the number of participants who receive their first MOUD prescription from the outpatient clinic after discharge from the ED in UC+CM compared to the UC-only condition. A secondary outcome will be the proportion of participants who kept attending outpatient MOUD treatment by the end of the 30-day study period between UC+CM and UC conditions. An exploratory outcome will be biochemically-verified illicit opioid abstinence measured at day 30.

Interventions

  • BEHAVIORAL Contingency Management
  • BEHAVIORAL Usual care as prescribed by the ED physicians

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-09-02
Est. Completion 2027-05
Phase NA

Sponsor

University of Vermont

162 total trials

What the Registry Record Tells You About NCT07129902

The ClinicalTrials.gov registry entry for NCT07129902 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Contingency Management is the first listed.

NCT07129902 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07129902 about?

NCT07129902 is a clinical study titled "Contingency Management to Improve Medication for Opioid Use Disorder Continuation After the Emergency Department". Project Summary The goal of this pilot clinical trial is to assess contingency management (CM) for increasing attendance at outpatient clinics after Medication for Opioid Use Disorder (MOUD) prescription and clinic referral occurred in the hospital Emergency Department (ED). * The researchers will ...

What is the current status of trial NCT07129902?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-09-02. Estimated completion is 2027-05.

What interventions are being tested in trial NCT07129902?

The interventions under investigation include: Contingency Management (BEHAVIORAL), Usual care as prescribed by the ED physicians (BEHAVIORAL).

Who is sponsoring clinical trial NCT07129902?

This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.